NKGen Biotech, Inc. (NKGN)
OTCMKTS
· Delayed Price · Currency is USD
0.180
-0.020 (-10.10%)
At close: Mar 9, 2026
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $23.48 million as of March 9, 2026. Its market cap has decreased by -17.11% in one year.
Market Cap
23.48M
Enterprise Value
61.67M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.18
Market Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from 338.09M to 23.48M, a decrease of -93.05%. That is a compound annual growth rate of -64.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 23.48M | 277.60% |
| Dec 31, 2025 | 6.22M | -73.65% |
| Dec 31, 2024 | 23.60M | -60.80% |
| Dec 29, 2023 | 60.19M | -82.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Provectus Biopharmaceuticals | 22.28M |
| Harvard Apparatus Regenerative Technology | 30.77M |
| Finch Therapeutics Group | 21.28M |
| EOM Pharmaceuticals Holdings | 20.25M |
| Oncotelic Therapeutics | 18.79M |
| Anebulo Pharmaceuticals | 18.56M |
| Inhibitor Therapeutics | 18.24M |
| ZIVO Bioscience | 37.49M |